Stolt-Nielsen Limited
LONDON, March 16, 2021 - Stolt-Nielsen Limited (Oslo Børs: SNI) today published its interactive Annual Report for the financial year ended November 30, 2020 online. You can download a pdf of the full report here.
Highlights include:
- A review of Stolt-Nielsen Limited's financial performance for the year
- Business reviews from each division
- Stolt-Nielsen’s approach to sustainability, including health and safety performance
- Environmental targets for each division and environmental performance for Stolt Tankers
- A short film: Stolt-Nielsen 2020 in Review
For additional information please contact:
Investor Relations
Jens F. Grüner-Hegge
Chief Financial Officer
+44 (0) 20 7611 8985
j.gruner-hegge@stolt.com
Media Enquiries
Ellie Davison
Head of Corporate Communications
+44 (0) 20 7611 8926
e.davison@stolt.com
About Stolt-Nielsen Limited
Stolt-Nielsen (SNL or the ‘Company’) is a long-term investor and manager of businesses focused on opportunities in
logistics, distribution and aquaculture. The Stolt-Nielsen portfolio consists of its three global bulk-liquid and
chemicals logistics businesses – Stolt Tankers, Stolthaven Terminals and Stolt Tank Containers – Stolt Sea Farm and
investments in LNG. Stolt-Nielsen Limited is listed on the Oslo Stock Exchange (Oslo Børs: SNI).
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.18.9.2025 08:01:56 CEST | Press release
Robex Announces Acceleration of Warrant Expiry Date
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom